Skip to main content
S 3159 117th Congress Senate International Affairs Asia Cardiovascular and respiratory health China Congressional oversight Department of Health and Human Services Drug trafficking and controlled substances Government employee pay, benefits, personnel management Government ethics and transparency, public corruption Government studies and investigations Health programs administration and funding Infectious and parasitic diseases Medical research National Institutes of Health (NIH) Public contracts and procurement Research administration and funding World health

FAUCI Act

Introduced: November 3, 2021 Introduced by: Ernst, Joni Republican · Iowa See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 3, 2021
Read twice and referred to the Committee on Foreign Relations.
Nov 3, 2021
Introduced in Senate
 Plain-English summary Congressional Research Service

Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act

This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.)

Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.

What's happening now November 3, 2021

Read twice and referred to the Committee on Foreign Relations.

 Committees of jurisdiction 1